Germany has voiced opposition to a US-backed proposal to waive patents on Covid-19 vaccines, saying they were not hindering production of the jabs.
Its government said “the protection of intellectual property is a source of innovation and must remain so”.
The European Union earlier said it was ready to talk about the proposal, and some states gave it their full backing.
Supporters of the plan say it will allow more manufactures to produce the life-saving vaccines.
They argue that this will increase access to jabs in poorer countries.
But opponents, including drug makers, say it may not have the desired effect.